The University of Texas, Christopher G Wood Advances in Urologic Oncology Symposium is open for registration. Omni Barton Creek, April 12th-14th. Please register to avoid missing out on the discounted room rate.

📣 ePub: ProBE-PC study of TR vs TP biopsy complications. 1st RCT ✅ 💪 Tremendous job by the team Urological InstituteAlbany Med Health System @AlbanyMed 🙏 to the 763 patients who volunteered Will discuss details, biases, blind spots Society of Urologic Oncology in 2 wks Amer. Urol. Assn. #prostate auajournals.org/doi/10.1097/JU…

Small renal masses are overwhelming low grade, genetically bland, and of low metastatic potential Phillip Pierorazio #kidneycancer #SUO2023 #SUO23

Great presentation of FALCON Comprehensive Consensus statements on #ProstateCancer #FocalTherapy by Lara Rodríguez Sánchez Confederación Americana de Urología (CAU) Focal Therapy Society #SUO23

Descent into Anchorage…like inverted clouds

51 years in the making till #GU24. OS benefit in adjuvant Renal Cancer is finally here. #KYN564

My sense is some men choose surgery over RT due to concerns over secondary malignancy. If you discuss secondary malignancies of RT (as I do), be fair and explain it appears to be an absolute risk of 0.5-1% at 25 years (many docs don't give risk estimate) auajournals.org/doi/full/10.10…

Very excited to share single surgeon experience with PFS-RARP with over 2 years of followup! Christopher Dall Bradley Mason Eshrar Choudhury 🇧🇩🌶 @GarijoMora Jillian Egan Jim Hu Society of Urologic Oncology Urologic Oncology sciencedirect.com/science/articl… TL;DR: 1. Increased urinary and overall EPIC-CP QOL

Absolutely thrilled to have matched at Cooper GME and be part of the Cooper Urology family!! Jeffrey Tomaszewski Ronak Gor, DO 🥳 So many people have helped make this dream a reality and I can’t wait to pay it forward ✨

Thank you to the speakers, attendees and industry sponsors The UT CGW meeting was a huge success. Shared ideas, research, trials, standards + most importantly time with friends and colleagues Looking forward to next years meeting April 4-6th at the Omni Barton Creek!

Impressive results presented by Joe Jacob MD, MCR at #AUA2024 from SunRISE-1 trial showing 82.8% CR rate at anytime and 12mo DOR 74.6%. Well tolerated. Andrea Necchi Hussein Sweiti, MD IBCG Bladder Cancer Advocacy Network

Hard to view this as anything other than abuse of the law for political purposes

Politics

Challenging the paradigm of “BCG-unresponsive” Bladder Cancer: Does additional BCG have an effect? 🧵 /1 The category ‘‘BCG-unresponsive’’ was formulated by expert opinion and adopted by the U.S. FDA to facilitate single-arm registration studies of novel agents for NMIBC This

Types of urology papers, I can’t stop laughing 😂…

🧵for the new residents and students on the meaning of 'French' and 'Gauge'. We've covered this on here in the past, but a lot of new people are starting on surgical rotations, so let's look at them again. As usual, we'll cover their history and what they mean. (1/ )

They survived an apocalypse—by sleeping through it - National Geographic The tardigrade remains my spirit animal. Amazing. apple.news/AMcdqxEcfT0aNh…

#SUO24 #WiFi

Now available in snow globe! ⁦Cooper University Health Care⁩

I've been a uro since the days of yore and - yet - I found this review helpful and interesting jamanetwork.com/journals/jamas…